RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. NT Investments
N

NT Investments portfolio

NT Investments has 1 portfolio company on record at Recent Funding. It led 1 of the 2 rounds it joined. Its most recent investment on record is Geneoscopy's $105M Series B+ round in January 2025, alongside Varia Ventures, Tri Locum Partners, SINC Fund and 6 others. That company is in Health and bio. It has co-invested with Morningside, LabCorp and Varia Ventures, most often Morningside (2 rounds).

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Rounds led: 1 of 2.
Capital in their rounds: $210M.
Latest deal: Geneoscopy · Jan 8, 2025.

What NT Investments invests in

How NT Investments invests

StageDealsCapital in rounds
Series B+ 2 100%$210M
YearDealsCapital in rounds
2021 1 50%$105M
2025 1 50%$105M

Share is of the 2 rounds on Recent Funding that name NT Investments. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

NT Investments portfolio companies

CompanyRound with NT InvestmentsTotal raisedLatest raise
GGeneoscopy
Health and bio
Series B+ · $105M$216.9MJan 8, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists NT Investments, which is a subset of its real portfolio. API: /api/v1/investors/nt-investments (get a free API key). More: the most active VC firms and new venture capital funds.